NEW YORK (360Dx) – The chief executive and a marketing executive of a New Jersey medical testing laboratory were sentenced to federal prison this week for their roles in a scheme in which Maryland pain management clinics referred urine specimens to the lab in return for $1.37 million in kickbacks, the US Attorney's Office District of Maryland announced on Friday.

Konstantin Bas, CEO of Accu Reference, was sentenced to a year and a day in prison, followed by three years of supervised release for his role in the scheme. He was ordered to forfeit $241,600 and pay a fine of $5,000.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Feb
26
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease. 

Mar
14

In this webinar, Dr. Wendy Béguelin of Weill Cornell Medicine will discuss how she used the BD Rhapsody single-cell RNA-seq platform and YFP floxed reporter mouse models to study how lymphoma-associated mutations disrupt the immune system by affecting GC B-cell states, explaining the biology of initiation of low-grade follicular lymphoma.

Mar
20
Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.